Immune checkpoints, such as cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1), transmit negative signals to CD8+ T-cell and reduce tumor-infiltrating lymphocytes during the anti-tumor process [13,14,15]. This evidence concerns the gene CTLA4 and neoplasm.